We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Dipstick Assay Evaluated for Liver Fluke Diagnosis

By LabMedica International staff writers
Posted on 22 May 2012
A dipstick assay has been developed to diagnose fascioliasis, and its diagnostic efficacy evaluated in comparison to an immunoassay.

The dipstick uses excretory–secretory antigen from Fasciola gigantica dotted onto nitrocellulose paper using a sheet Mini-Protean II multiscreen apparatus to which human serum is applied. More...


Parasitologists at Ain Shams University (Cairo, Egypt) collected blood samples were collected from 60 individuals categorized into three groups. Group I consisted of 30 fascioliasis patients, diagnosed by detection of eggs of Fasciola in the stool and serologically by positive indirect hemagglutination test. Group II consisted of 20 patients with other parasitic diseases, and Group III consisted of 20 healthy individuals proven negative for fascioliasis and other parasitic diseases.

The enzyme linked immunosorbent assay (ELISA) was carried using a standard protocol and the absorbance was measured at 450 nm using a microplate reader. Samples were considered positive if their optical density was greater than the mean of healthy control samples plus three standard deviations. On the dipstick, a dark purple to brown band indicated a positive reaction.

The dipsticks' accuracy was 98.3%, with a sensitivity of 100%, a specificity of 96.7%, and negative predictive value of 100%. The sensitivity, specificity, and diagnostic accuracy of the ELISA were 100%, 96.7%, and 98.3%, respectively. The nitrocellulose paper and sheet Mini-Protean II multiscreen apparatus are both products of Bio-Rad (Hercules, CA, USA).

The authors concluded that the dipstick is a simple antigen and serum-conservative test requires only micrograms of parasite antigen and 20 µL of patient's sera. This test can be carried out while the patients wait, and would be more practical than what is currently done especially in rural areas and district hospitals. The test has its merit in being both qualitative, able to screen large numbers of blood samples, and quantitative assay, as the end-point titration of individual's sera can be determined. It is estimated that over 2.4 million people are infected with Fasciola species worldwide and around 91 million are at risk of infection. The study was published in the May 2012 issue of the journal Parasitology Research.

Related Links:
Ain Shams University
Bio-Rad



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Prefilled Tubes
Prefilled 5.0ml Tubes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.